C. Wanner

1.0k total citations
24 papers, 376 citations indexed

About

C. Wanner is a scholar working on Nephrology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C. Wanner has authored 24 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 6 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C. Wanner's work include Lipoproteins and Cardiovascular Health (4 papers), Dialysis and Renal Disease Management (4 papers) and Cancer, Lipids, and Metabolism (3 papers). C. Wanner is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Dialysis and Renal Disease Management (4 papers) and Cancer, Lipids, and Metabolism (3 papers). C. Wanner collaborates with scholars based in Germany, Netherlands and Italy. C. Wanner's co-authors include Kitty J. Jager, Vianda S Stel, Moniek W.M. van de Luijtgaarden, Edzard Schwedhelm, Rainer H. Böger, Sabine Pinnetti, Jan Galle, Thomas Quaschning, P. Schollmeyer and Annette Krämer‐Guth and has published in prestigious journals such as Scientific Reports, Kidney International and European Heart Journal.

In The Last Decade

C. Wanner

22 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Wanner Germany 11 188 100 89 70 59 24 376
F Gómez-Campderá Spain 12 270 1.4× 157 1.6× 68 0.8× 110 1.6× 78 1.3× 19 546
Gerjan Navis Netherlands 11 133 0.7× 160 1.6× 100 1.1× 101 1.4× 107 1.8× 15 415
J. Chahin Spain 9 311 1.7× 62 0.6× 94 1.1× 60 0.9× 34 0.6× 14 445
Ron T. Gansevoort Netherlands 3 290 1.5× 252 2.5× 102 1.1× 61 0.9× 70 1.2× 5 517
C Hottelart France 10 168 0.9× 73 0.7× 126 1.4× 144 2.1× 69 1.2× 15 433
Fatemeh Hayati Iran 10 172 0.9× 50 0.5× 66 0.7× 70 1.0× 60 1.0× 26 385
Luca Visconti Italy 13 175 0.9× 44 0.4× 61 0.7× 59 0.8× 91 1.5× 26 435
Ziad Massy France 5 181 1.0× 137 1.4× 107 1.2× 91 1.3× 56 0.9× 11 417
Rossella Siligato Italy 12 169 0.9× 75 0.8× 91 1.0× 49 0.7× 49 0.8× 31 433
Mai Ots Estonia 13 269 1.4× 228 2.3× 91 1.0× 82 1.2× 54 0.9× 19 579

Countries citing papers authored by C. Wanner

Since Specialization
Citations

This map shows the geographic impact of C. Wanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Wanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Wanner more than expected).

Fields of papers citing papers by C. Wanner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Wanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Wanner. The network helps show where C. Wanner may publish in the future.

Co-authorship network of co-authors of C. Wanner

This figure shows the co-authorship network connecting the top 25 collaborators of C. Wanner. A scholar is included among the top collaborators of C. Wanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Wanner. C. Wanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cozzolino, Mario, Fergus Caskey, Claudia Torino, et al.. (2025). Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL study. Kidney International. 108(6). 1135–1145. 1 indexed citations
2.
Balfanz, Paul, Dirk Müller‐Wieland, Stephan Jonas, et al.. (2024). Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study. Scientific Reports. 14(1). 30290–30290. 2 indexed citations
3.
Morbach, Caroline, Vladimir Cejka, Michael Stach, et al.. (2024). Determinants and reference values of the 6-min walk distance in the general population—results of the population-based STAAB cohort study. Clinical Research in Cardiology. 114(9). 1098–1108. 2 indexed citations
4.
Agarwal, Rajiv, Bertram Pitt, Peter Rossing, et al.. (2022). In patients with type 2 diabetes chronic kidney disease is a modifiable cardiovascular risk factor. European Heart Journal. 43(Supplement_2). 2 indexed citations
5.
Singh, Ajay, Anjali Acharya, Renato D. Lópes, et al.. (2022). Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials. European Heart Journal. 43(Supplement_2). 4 indexed citations
6.
Blankestijn, Peter J., Annette Bruchfeld, Giovambattista Capasso, et al.. (2019). The nephrology crystal ball: the medium-term future. Nephrology Dialysis Transplantation. 35(2). 222–226. 5 indexed citations
7.
Wanner, C., et al.. (2015). Long-Term Outcome in Diabetic Patients on Hemodialysis Treatment. Contributions to nephrology. 73. 163–169.
8.
Stralen, Karlijn J. van, C. Wanner, Gema Ariceta, et al.. (2014). Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry. Nephrology Dialysis Transplantation. 29(suppl 4). iv1–iv8. 47 indexed citations
9.
Locatelli, Francesco, Goce Spasovski, Nada Dimković, et al.. (2013). The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study. Nephrology Dialysis Transplantation. 29(5). 1061–1073. 23 indexed citations
10.
Luijtgaarden, Moniek W.M. van de, et al.. (2012). Renal replacement therapy in Europe--a summary of the 2009 ERA-EDTA Registry Annual Report. Clinical Kidney Journal. 5(2). 109–119. 15 indexed citations
11.
Jager, Kitty J., Vianda S Stel, Carmine Zoccali, C. Wanner, & Friedo W. Dekker. (2010). The issue of studying the effect of interventions in renal replacement therapy -- to what extent may we be deceived by selection and competing risk?. Nephrology Dialysis Transplantation. 25(12). 3836–3839. 23 indexed citations
12.
Stel, Vianda S, et al.. (2010). The 2008 ERA-EDTA Registry Annual Report--a precis. Clinical Kidney Journal. 4(1). 1–13. 67 indexed citations
13.
Galle, Jan, et al.. (2008). Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy. Nephrology Dialysis Transplantation. 23(10). 3174–3183. 75 indexed citations
14.
Hörl, Walter H., Yves Vanrenterghem, Pedro Aljama, et al.. (2007). OPTA: Optimal treatment of anaemia in patients with chronic kidney disease (CKD). Nephrology Dialysis Transplantation. 22(Supplement 3). iii20–iii26. 4 indexed citations
15.
Wanner, C., et al.. (2000). Impact of dyslipidaemia in renal transplant recipients. Current Opinion in Urology. 10(2). 77–80. 15 indexed citations
16.
Krämer‐Guth, Annette, Thomas Quaschning, Hermann Pavenstädt, et al.. (1997). Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells. Nephrology Dialysis Transplantation. 12(7). 1336–1343. 8 indexed citations
17.
Krämer‐Guth, Annette, et al.. (1996). Potential role of lipids in the progression of diabetic nephropathy.. PubMed. 46(4). 262–5. 16 indexed citations
18.
Nauck, Matthias, Annette Krämer‐Guth, Claus Luley, et al.. (1995). Enhanced receptor mediated uptake of apo E4Freiburg (28 Leu - > Pro) containing VLDL by human skin fibroblasts. Atherosclerosis. 115. S38–S38. 1 indexed citations
19.
Wanner, C., et al.. (1994). Lipoprotein(a) in renal patients: is it a key factor in the high cardiovascular mortality?. Nephrology Dialysis Transplantation. 9(8). 1066–1068. 7 indexed citations
20.
Nauck, Matthias, Hermann Pavenstädt, Susanne Schwedler, et al.. (1993). Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells. Kidney International. 44(6). 1341–1351. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Gómez-Campderá Breakdown of academic impact, for papers by Gerjan Navis Breakdown of academic impact, for papers by J. Chahin Breakdown of academic impact, for papers by Ron T. Gansevoort Breakdown of academic impact, for papers by C Hottelart Breakdown of academic impact, for papers by Fatemeh Hayati Breakdown of academic impact, for papers by Luca Visconti Breakdown of academic impact, for papers by Ziad Massy Breakdown of academic impact, for papers by Rossella Siligato Breakdown of academic impact, for papers by Mai Ots
Rankless by CCL
2026